Jeff Cislini, SVP & General Counsel at Revolution Medicines, Inc. (RVMD), sold 3,366 shares at $195.01 ($671K) on 2026-09-16, disclosed to the SEC on 2026-09-18.
Scheduled sale ($671k) by SVP & General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $195.01 | 52 | $10K | 1.5% |
| 2 | $199.30 | 3,314 | $660K | 98.5% |
| Total | $199.24 avg | 3,366 | $671K | 100% |
| Filing → |
| RVMD | SELL | 2026-06-18 | $337K | — | Filing → |
| RVMD | SELL | 2026-03-19 | $470K | — | Filing → |
| RVMD | SELL | 2026-01-23 | $105K | — | Filing → |